Journal of Applied Physiology Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 104: 1641-1647, 2008. First published April 10, 2008; doi:10.1152/japplphysiol.00062.2008
8750-7587/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/6/1641    most recent
00062.2008v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nunes, R. B.
Right arrow Articles by Dall'Ago, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nunes, R. B.
Right arrow Articles by Dall'Ago, P.

Physical exercise improves plasmatic levels of IL-10, left ventricular end-diastolic pressure, and muscle lipid peroxidation in chronic heart failure rats

R. B. Nunes,1 M. Tonetto,1 N. Machado,1 M. Chazan,1 T. G. Heck,1 A. B. G. Veiga,2 and P. Dall'Ago1

Laboratories of 1Cardiovascular Physiology and 2Molecular Biology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rio Grande do Sul, Brazil

Submitted 21 January 2008 ; accepted in final form 7 April 2008


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
Chronic heart failure (CHF) is characterized by left ventricular dysfunction, resulting in hemodynamic changes, sustained inflammatory state, as well as increase in oxidative stress. Physical exercise has been described as an important nonpharmacological procedure in the treatment of CHF, contributing to the improvement of the clinical outcomes in this disease. This study evaluated the effects of physical training on hemodynamics, muscle lipid peroxidation, and plasmatic levels of IL-10 in CHF rats. The left coronary artery was ligated to induce CHF, or sham operation was performed in control groups. Rats were assigned to one of four groups: trained CHF (T-CHF, n = 10), sedentary CHF (S-CHF, n = 10), trained sham (T-Sham, n = 10), or sedentary sham (S-Sham, n = 10). Trained animals had carried out a swimming protocol, 60 min/day, 5 days/wk, during 8 wk, whereas sedentary animals remained without training. Eight weeks of physical training promoted an improvement of diastolic function represented by a reduction of the left ventricular end-diastolic pressure in the T-CHF group compared with the S-CHF group (P < 0.05). Lipid peroxidation evaluated in gastrocnemius muscle using thiobarbituric acid reactive substance assay was higher in the S-CHF group compared with all other groups (P < 0.05). However, there were no differences between T-CHF compared with S-Sham and T-Sham groups. The plasmatic levels of IL-10 were lower in the S-CHF group compared with all other groups (P < 0.05). These findings demonstrate that regular physical training using a swimming protocol, with duration of 8 wk, improves the cardiac function and the anti-inflammatory response and reduces muscle cellular damage.

myocardial infarction; inflammation


FUNCTIONAL LIMITATION IN CHRONIC heart failure (CHF) is determined by a combination of factors that include cardiovascular (43), skeletal muscle (15, 32, 46), and ventilatory response abnormalities (13, 36) during exercise. In CHF, these alterations are multifactorial, complex, and correlated (13). Exercise intolerance is the most common symptom observed in CHF and is associated with early muscle fatigue and dyspnea, which may reflect a reduced functional capacity (32, 54). In previous studies, functional capacity was mainly associated with skeletal muscle alterations due to a low-perfusion syndrome, which is a result of the neurohumoral hyperactive state that could be exaggerated during exercise (23, 42, 53). However, more recently, studies have demonstrated that mainly intrinsic metabolic and inflammatory abnormalities of the skeletal muscle are related to increase in the muscle fatigability (14, 15, 32, 43, 46). Several earlier studies have demonstrated reduction of skeletal muscle oxidative capacity (14), muscular atrophy (17, 48), as well as changes in the distribution of the fiber type (14, 15, 54) in CHF. In fact, severe left ventricular dysfunction lowers the activity of oxidative enzymes independently of muscle fiber composition (15). Beyond morphological and biochemical changes, the presence of increased plasmatic and muscular levels of proinflammatory cytokines, as well as low levels of anti-inflammatory cytokines, mainly interleukin-10 (IL-10), is well documented in patients with CHF (20). In this regard, the sustained inflammatory pattern is observed with a notable imbalance between pro- and anti-inflammatory cytokines (3, 4, 37, 52). Moreover, CHF is characterized by high levels of oxidative stress (47). The substantial participation of the aforementioned factors on circulatory and skeletal muscle dysfunction during physical exercise has already been shown, which perpetuates the functional limitation observed in CHF.

Recent reports have demonstrated that physical exercise not only reverts the abnormalities of the skeletal muscle, but also improves CHF symptoms (5, 11, 44). The beneficial effects of exercise on the skeletal muscle system include muscular hypertrophy, improvement of caquexia (24), and increase in the oxidative metabolism (26). More recently, a possible anti-inflammatory pivotal role was suggested for regular physical exercise, both in healthy individuals (25, 40, 55) and in chronic inflammatory conditions (30, 37), as observed in CHF. In accordance with this hypothesis, enhanced production of the anti-inflammatory factors from muscular contraction has been observed during physical exercise. However, the effect of physical exercise on the inflammatory condition in CHF remains poorly clarified. Furthermore, to the best of our knowledge, there are no published studies describing the effects of physical exercise on IL-10 levels and muscle oxidative stress in the CHF experimental model. Because of its potent anti-inflammatory effects, IL-10 has been implicated in a number of inflammatory conditions as an important regulator of the immune and inflammatory systems (34). Moreover, in vitro and in vivo studies suggest that IL-10 could be a potentially useful therapeutic agent for the treatment of acute and chronic, systemic, and localized inflammatory reactions.

The animal model of CHF resembles the chronic syndrome observed during heart failure in humans (18), allowing an important alternative to the study and understanding of CHF state. In addition, the precise mechanism of the functional limitation observed in CHF is still poorly understood.

On the basis of these observations, we hypothesized that physical exercise could be associated with improvements in hemodynamics, oxidative stress, and inflammatory condition in rats with CHF. Therefore, the aim of the present study was to evaluate the effects of physical exercise on hemodynamic function, skeletal muscle oxidative stress, and plasmatic levels of IL-10 in an animal model of CHF subsequent to myocardial infarction (MI).


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
Animals

Experiments were performed on 40 male Wistar rats weighing between 200 and 250 g (~90 days of age), obtained from the Animal Breeding Unit of the Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA). They were housed three per cage, receiving food and water ad libitum in an animal room under 12:12-h light-dark cycle, at 22°C. The investigation followed the ethical rules established by the Guide for Care and Use of Experimental Animals published by the National Institutes of Health (NIH publication no. 85-23, revised in 1996). All procedures outlined in this study were approved by the Ethics Committee Research of the UFCSPA (protocol 009/04).

Surgery to Induce MI

Rats were anesthetized with xilazine (12 mg/kg ip) and ketamine (90 mg/kg ip), intubated, and artificially ventilated (SamWay VR 15) with a respiratory frequency of 60 breaths/min and an oxygen inspired fraction of 100%. MI was induced as previously described by Pfeffer et al. (42). The heart was exposed through left thoracotomy between the fourth and fifth ribs. For the animals in which MI was induced, a mononylon suture 6-0 was passed in the main left descending coronary artery, in a point between 1 and 2 mm distal to the edge of the left atrium, and the left coronary artery was ligated. Sham-operated animals underwent the same procedure without tying the suture and served as control rats. The thorax was closed, the skin was sutured, and the pneumothorax was drained by a continuous aspiration system.

Experimental Design

After MI, rats were allowed a minimum of 4 wk of recovery (the necessary time to achieve the development of the CHF state) (42). Then they were assigned to one of four experimental groups: trained CHF rats (T-CHF, n = 10), sedentary CHF rats (S-CHF, n = 10), trained sham rats (T-Sham, n = 10), and sedentary sham rats (S-Sham, n = 10).

Physical exercise program.   Four weeks after the MI or sham surgery, rats were adapted to a flat tank with tepid water (30–32°C) during 60 min, 5 days/wk, throughout 1 wk. In the following week, the animals started the protocol of physical exercise (60 min/day, 5 days/wk, during 8 wk). In the first 7 days, the rats swam for 20 min; on the subsequent days of training, the swimming time was extended to 30 min in the second week, 40 min in the third week, and finally 50 min in the fourth week. At the end of the fourth week until the end of the program (with 8 full wk), the animals had exercised continuously during 60 min. The tanks in which physical training was carried out presented capacity of 50 liters, and the water temperature was kept between 30 and 32°C. The swimming program followed the recommendations of the American Physiological Society (29).

Surgical preparation for hemodynamic evaluation.   After 8 wk of physical exercise, animals were anesthetized with xilazine (12 mg/kg ip) and ketamine (90 mg/kg ip). A small incision in the anterior cervical region was performed for the insertion of a polyethylene catheter (PE-50) into the right carotid artery. The arterial pressure was first recorded during a 5-min period through a connection of the arterial cannula to a pressure transducer (strain-gauge, Narco Biosystem Miniature Pulse Transducer RP-155, Houston, TX), coupled to a pressure amplifier (Stemtec). Then the catheter was positioned into the left ventricle, and pulse wave was monitored by the typical graphic registration of ventricular pressure and was also recorded for 5 min.

Pressure analogical signals were digitalized by a data-acquisition system (CODAS-Data Acquisition System) with sampling rate of 2,000 Hz. These data were used to determine mean arterial pressure, heart rate, left ventricular systolic pressure, left ventricular maximum change in pressure over time, left ventricular minimum change in pressure over time, and left ventricular end-diastolic pressure (LVEDP). This last parameter was determined manually by the detection of the point of inflection to the end of diastoles from the analysis of the wave of ventricular pressure.

Blood samples and muscle collection.   Blood samples were drawn from the catheter positioned in the right carotid artery, collected into a 1.5-ml tube containing sodium citrate 3.2% (1:9 vol/vol), centrifuged at 500 g and 4°C, and stored at –80°C. Animals were killed after blood draw, and the gastrocnemius muscle of the right leg of each rat was removed, frozen in liquid nitrogen, and stored at –80°C.

Lung and hepatic congestion.   Lungs and liver of each animal were removed, weighed, and dehydrated (80°C) for 48 h and then weighed again to evaluate the water percentage.

Infarct size.   Hearts were removed and weighed. Left ventricles were filled with an insufflating latex balloon and placed in formaldehyde for 24 h for subsequent analysis of the size of the infarction area, determined by planimetry (31).

Plasmatic levels of IL-10.   IL-10 levels present in the plasma of each animal were determined by ELISA using the BD OptEIA ELISA Kit (BD Biosciences Pharmingen) following the manufacturer's instructions. Measurements were performed in duplicates for calculation of results.

Muscle sample preparation.   Gastrocnemius muscle samples were homogenized (7% wt/vol) in 120 mM KCl-0.30 mM phosphate-buffered saline, pH 7.4, containing 0.5 mM phenylmethanesulfonyl fluoride (0–4°C). The suspension was centrifuged at 600 g for 10 min, at 4°C, to remove cell debris, and the supernatant was used as sample. Protein concentration of muscle samples was measured by the Bradford method (8), using bovine serum albumin (1 mg/ml) as standard. Results are expressed in milligram of protein per milliliter of sample.

Oxidative Stress

Chemiluminescence.   Chemiluminescence was measured in a liquid scintillation counter in the out-of-coincidence mode (LKB Rack Beta Liquid Scintillation Spectrometer 1215, LKB Produkter). Gastrocnemius homogenates were placed in low-potassium vials at a protein concentration of 0.5–1.0 mg/ml in a reaction medium consisting of 120 mM KCl and 30 mM phosphate-buffered saline (pH 7.4). Measurement was started by the addition of tert-butyl hydroperoxide, and data were expressed as counts per second per milligram of protein.

Thiobarbituric acid reactive substance.   To measure lipid peroxidation, homogenates were precipitated with 10% TCA, centrifuged, and incubated with thiobarbituric acid (Sigma, Chem.) for 60 min at 100°C. Thiobarbituric acid reactive substance (TBARS) was extracted using butanol (1:1 vol/vol). After centrifugation, the absorbance of the butanol layer was measured at 535 nm (9). The amount of TBARS formed was expressed in nanomoles of malondialdehyde per milligram of protein. Malondialdehyde standards were prepared from 1,1,3,3-tetramethoxypropane.

Catalase activity.   Catalase activity was determined by following the decrease at 240-nm absorbance in a reaction medium containing 50 mM/l phosphate-buffered saline (pH 7.2) and 10 mM/l hydrogen peroxide (H2O2). It was expressed as microliters of H2O2 reduced per second per milligram of protein (1).

Statistical Analysis

Mean value and SD was calculated for each variable and group. Data were compared among groups with one-way ANOVA followed by Student-Newman-Keuls post hoc test. A P value of <0.05 was considered statistically significant. The GraphPad Prism 4 program (GraphPad Software, San Diego, CA) for Windows was used as computational tool for the data analysis.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
Mortality in MI-induced CHF rats, during or immediately after surgery, was ~35%. There were no behaviors associated with stress or adverse effects in rats that participated in the swimming protocol.

Body Weight, Infarct Size, Pulmonary and Hepatic Congestion

MI was induced in 20 animals: 10 in the S-CHF group and 10 in the T-CHF group. Similarly, sham surgery was performed in 20 animals: 10 in the S-Sham group and 10 in the T-Sham group. All animals were weighed at the end of the experiment. No significant mean weight differences were detected among the four groups at any moment of the study (Table 1). A large area of scarring was observed in the anterior wall of the left ventricle of infarcted rats. The infarct size was determined in a percentage of the left ventricle total area, as an indication of ventricular dysfunction. For the groups S-CHF and T-CHF, the infarct size was 34.08 ± 1.4 vs. 34.71 ± 1.45% (Table 1), and there were no statistical differences between trained and sedentary groups. No detectable infarcts were found among the sedentary and the trained sham-operated rats.


View this table:
[in this window]
[in a new window]

 
Table 1. Body, tissue, and infarct characteristics of sham-operated rats and rats with left ventricular dysfunction

 
Lung and liver wet-to-dry weight ratios were used to determine the percentage of water in these tissues, as an indicative of congestion. Table 1 shows that the groups of rats with CHF demonstrated an increase in wet-to-dry weight ratios in the lungs, as well as in the liver, compared with the sham groups, suggesting that these rats had significant lung and liver congestion. However, there were no differences in the liver wet-to-dry weight ratio between T-CHF and sham groups (Table 1).

Hemodynamic Variables

All CHF animals, either trained or sedentary, presented values of LVEDP above 20 mmHg, characterizing the presence of important ventricular dysfunction (35), compared with the sham groups (P < 0.001, Fig. 1A). However, as shown in Fig. 1A, when the T-CHF group was compared with the S-CHF group, there was an improvement of the diastolic function, represented by a reduction, although modest, of the LVEDP in T-CHF group (22.9 ± 3.2 vs. 26.2 ± 4.5 mmHg, P < 0.05). In addition, the LVEDP was lower in the T-Sham group compared with the S-Sham group (Fig. 1A).


Figure 1
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 1. Hemodynamic characteristics of sham and chronic heart failure (CHF) rats. The groups are as follows: sedentary sham group (S-Sham), trained sham group (T-Sham), sedentary CHF group (S-CHF), and trained CHF group (T-CHF); n = 10 for all groups. A: left ventricular end-diastolic pressure (LVEDP). *P < 0.05 compared with S-Sham, T-Sham, and S-CHF. {dagger}P < 0.001 compared with S-Sham and T-Sham. {ddagger}P < 0.05 compared with S-Sham. B: left ventricular systolic pressure (LVSP). **P < 0.05 compared with T-CHF and S-CHF. C: left ventricular maximum change in pressure over time (dP/dtmax). {dagger}P < 0.001 compared with S-Sham and T-Sham. *P < 0.05 compared with S-Sham and T-Sham. D: left ventricular minimum dP/dt (dP/dtmin). *P < 0.001 compared with S-Sham and T-Sham. Values are means ± SD.

 
Left ventricular systolic pressure was higher in the T-Sham group compared with T-CHF and S-CHF groups, without a difference between T-Sham and S-Sham groups (Fig. 1B). CHF rats exhibited depressed left ventricular maximum change in pressure over time and minimum change in pressure over time (Fig. 1, C and D, respectively). The mean arterial pressure measured during anesthesia was lower in the CHF groups compared with sham groups (S-Sham: 105.6 ± 15; T-Sham: 102.9 ± 11.6; S-CHF: 87.9 ± 12.1; and T-CHF: 90.2 ± 8.8 mmHg, P < 0.05). In contrast, there were no differences in heart rate measured during anesthesia (data not shown).

IL-10 Plasmatic Levels and Muscle Oxidative Stress

The IL-10 plasmatic concentration, analyzed by ELISA, was lower in the S-CHF group compared with all other groups (P < 0.05). The T-CHF group demonstrated an improvement of IL-10 plasmatic levels as a consequence of physical exercise (Fig. 2A). Muscular oxidative stress was evaluated in the gastrocnemius of four experimental groups. Lipid peroxidation measured by TBARS was increased in the S-CHF group compared with all other groups (P < 0.05, Fig. 2B). In contrast, when we compared the T-CHF group with the sham groups, there were no differences in lipid peroxidation, suggesting that physical exercise reduces muscle lipid peroxidation in CHF rats. However, there were no significant differences in oxidative damage measured by chemiluminescence and by catalase enzyme activity (data not shown). In addition, IL-10 plasma levels did not correlated with TBARS (r = 0.49; P = 0.09).


Figure 2
View larger version (14K):
[in this window]
[in a new window]

 
Fig. 2. Effects of physical exercise on interleukin (IL)-10 plasmatic levels and muscle lipid peroxidation. Groups are as described in Fig. 1 legend; n = 4 for all groups. A: IL-10 plasmatic levels. *P < 0.05 compared with S-CHF. {dagger}P < 0.001 compared with S-Sham and T-Sham. B: lipid peroxidation measured by the thiobarbituric acid reactive substances (TBARS) assay. *P < 0.05 compared with all groups. Values are means ± SD.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
The present study sought to evaluate the impact of an 8-wk protocol of physical exercise on hemodynamic variables, oxidative stress, and IL-10 plasmatic levels in Wistar rats with CHF subsequent to MI. A large number of investigations have been done in recent years to study the effects of physical exercise in the CHF state. However, investigations analyzing improvement of the LVEDP and the anti-inflammatory and antioxidant effects of a regular physical training are poor, especially with animal models of CHF. Therefore, we conducted this study to test the hypothesis that an 8-wk swimming program could be associated with an improvement in LVEDP, skeletal muscle oxidative stress, and plasmatic concentration of IL-10 in rats with CHF. The present report demonstrates, for the first time, that physical exercise based on a swimming protocol is able to reduce LVEDP, increase IL-10 plasmatic levels, and improve the levels of muscular lipid peroxidation.

The left coronary artery ligature produces marked left ventricular dysfunction that is directly related to the size of the infarcted area (10, 42) and simulates the most common cause of CHF. In our study, the average size of the infarcted area was around 34% of the total left ventricle area in CHF groups, which produced a significant increase in the end-diastolic pressure values (>20 mmHg) of the left ventricle. This standard value has been assumed to characterize the development of the severe CHF (35). The hemodynamic dysfunction observed induces the development of structural and functional muscle changes, which, in turn, are related to impaired functional capacity (32, 46), muscular oxidative stress (6, 23, 49), increase in inflammatory cytokines, as well as reduction in the activity of anti-inflammatory cytokines (51).

Clinical studies have clearly demonstrated that the improvement of systemic (peripheral) function during CHF is associated with increased survival. However, pharmacological therapies, which increase left ventricular inotropic function, are found to be associated with an increase in mortality (12, 39, 49). On the other hand, many studies have demonstrated that physical exercise is a powerful factor to improve peripheral function in CHF, both in humans (5, 22, 44) and in animal models (53), without increases in mortality. These data support the notion that survival and prognosis were associated with the ability of the subject to adapt to a state of pump dysfunction rather than to the magnitude of change in pump function.

The results of our study have pointed out a positive effect of an 8-wk physical exercise program on cardiac function. The observed reduction on the LVEDP was 12.6% in the T-CHF group, compared with the S-CHF group. Similarly, the T-Sham group presented lower LVEDP values (17.1%) compared with S-Sham group, suggesting a relationship between the reduction in LVEDP and physical exercise, since it is present in both infarcted and noninfarcted trained rats. Accordingly, a recent meta-analysis about the effects of exercise in heart failure patients has demonstrated that programs of aerobic exercise can modify the cardiac remodeling and increase the functional capacity (22).

Among many subcellular changes, an increase in oxidative stress has been implicated in the development and progression of heart failure (27, 28, 50). The functional improvement resulting from physical exercise could be explained, at least in part, by a reduction of oxidative stress, an improvement of endothelial function, and an increase in anti-inflammatory cytokine levels, together with a reduction of proinflammatory cytokine levels (5, 11, 25, 55). Tissue levels of oxidative stress are determined by a balance between the production of reactive oxygen species and the enzymatic and nonenzymatic antioxidant defense production (23). The increase in oxidative stress may cause a reactive increase in the expression of antioxidant defense (23). In CHF, markers of oxidative damage, such as TBARS, are raised in plasma and tissue, and its levels are associated with the disease severity (6). In the present study, we could observe that physical exercise reduces TBARS activity in skeletal muscle of T-CHF rats in relation to the S-CHF group, showing a reduction of lipid peroxidation as a consequence of physical exercise. According to Moller et al. (33), physical exercise is related to oxidative stress in two ways: on one hand, acute physical exercise accelerates the oxidative metabolism, generating higher formation of free radicals, and, on the other hand, a protective antioxidant effect may be generated through regular sessions of physical exercise. In the present report, we selected the swimming protocol as the method of physical training, which was showed to be enough to reduce the lipid peroxidation levels in gastrocnemius of T-CHF rats. Surprisingly, the increase in lipid peroxidation of the CHF rats was not accompanied by an increase in catalase activity. There are several possibilities that may account for this disparity in our results, such as differences in the techniques used to determine catalase activity (using chemiluminescence) or differences in the effects of physical training between groups and the muscle capacity of adapting to chronic oxidative stress. In addition, regulation of antioxidant enzymes as a response to acute or chronic physical exercise stress is determined not only by the levels of oxidative stress but also by the availability of trace elements, such as Cu, Zn, Mn, Fe, and Se, which are reduced after exercise (2). Alternatively, IL-10 could be an important antioxidant agent, reducing free-radical generation (16).

Regular physical training has promoted an antioxidant enzymatic adaptation that reduces the free-radical-induced cellular damage (45). In healthy animals, the vasoconstriction induced by sympathetic nervous system is attenuated by nitric oxide (NO) production. Nevertheless, during CHF, NO production, release, and activity may be changed by oxidative stress. Physical training seems to improve the muscular metabolism by modifying the cellular redox state and inducing NO production (19, 50). In this regard, rats with CHF have a reduction of the endothelium-dependent vasodilatation in the skeletal muscle (53). On the other hand, physical exercise may restore, at least in part, the normal vasodilatation response in skeletal muscle. Therefore, the improvement in oxidative damage may be associated with better endothelium vasodilatation response, contributing to an improvement of the systemic function during CHF.

A large number of studies have suggested an increase in the activation of the immunological system with a marked rise in the circulating concentrations of proinflammatory cytokines during CHF, which can be observed in both humans and animals (20, 21, 41, 51). Physical exercise has been suggested as an important precursor in the activation of mechanisms of anti-inflammatory factors (25, 38, 40). In the present report, we demonstrated that CHF can reduce IL-10 levels in sedentary animals, while an 8-wk physical training can raise the IL-10 plasmatic concentration in T-CHF animals. IL-10 is a powerful anti-inflammatory cytokine that inhibits the release of TNF-{alpha} by peripheral blood mononuclear cells in CHF. This effect appears to be independent of disease severity, plasma cytokine levels, and endotoxin activity (7). Our results are consistent with previous investigations in which physical exercise induced an increase in anti-inflammatory cytokines in normal subjects (40). The authors suggested that the process of muscular contraction during exercise could stimulate the transcription of IL-6 mRNA, responsible for activating the cascade of anti-inflammatory cytokines, such as IL-10. This anti-inflammatory effect appears to be related to the regular physical training and the level of physical conditioning, because higher plasmatic levels of IL-10 are observed in physically active subjects, but not in sedentary ones (25). On the other hand, when the exercise is acutely performed, an increase of proinflammatory cytokines could be observed (55).

In conclusion, a regular 8-wk swimming training protocol for Wistar rats with CHF induced by MI was able to improve LVEDP and the anti-inflammatory response, with a significant increase in IL-10 plasmatic concentrations. In addition, our findings show that exercise decreases muscle cellular damage evaluated by TBARS. As it is fully applicable to humans, the present report provides an important contribution for the understanding of the benefits of regular physical exercise upon systemic alterations of CHF. Taking into account that CHF is a syndrome with systemic impacts, the use of simple, safe, and inexpensive strategies, such as physical exercise, can improve the patient functional capacity with a nonpharmacological therapeutic procedure that can be well accepted.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by grants from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasília, Brazil, and Principal Regional Office for Asia and the Pacific/Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.


    DISCLOSURES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
The authors do not have a financial relationship with a commercial entity that has an interest in the subject of this paper.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 
We are thankful to Dr. Alberto Antonio Rasia-Filho, Dr. Paulo Ivo Homen de Bittencourt, Maurício Krause, and João Fernandes for support during the development of this study.


    FOOTNOTES
 

Address for reprint requests and other correspondence: P. Dall'Ago, Physiological Sciences Dept., UFCSPA, Sarmento Leite, 245/308, 90050-170, Porto Alegre, RS, Brazil (e-mail: pdallago{at}pq.cnpq.br)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 DISCLOSURES
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Aebi H. Catalase in vitro. Methods Enzymol 105: 121–126, 1984.[Web of Science][Medline]
  2. Banerjee AK, Mandal A, Chanda D, Chakraborti S. Oxidant, antioxidant and physical exercise. Mol Cell Biochem 253: 307–312, 2003.[CrossRef][Web of Science][Medline]
  3. Batista ML Jr, Santos RV, Cunha LM, Mattos K, Oliveira EM, Seelaender MC, Costa Rosa LF. Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure. Cytokine 34: 284–290, 2006.[CrossRef][Web of Science][Medline]
  4. Batista ML Jr, Santos RV, Oliveira EM, Seelaender MC, Costa Rosa LF. Endurance training restores peritoneal macrophage function in post-MI congestive heart failure rats. J Appl Physiol 102: 2033–2039, 2007.[Abstract/Free Full Text]
  5. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99: 1173–1182, 1999.[Abstract/Free Full Text]
  6. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 65: 245–248, 1991.[Abstract/Free Full Text]
  7. Bolger AP, Sharma R, von Haehling S, Doehner W, Oliver B, Rauchhaus M, Coats AJ, Adcock IM, Anker SD. Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol 90: 384–389, 2002.[CrossRef][Web of Science][Medline]
  8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976.[CrossRef][Web of Science][Medline]
  9. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 52: 302–310, 1978.[Medline]
  10. Chimenti S, Carlo E, Masson S, Bai A, Latini R. Myocardial infarction: animal models. Methods Mol Med 98: 217–226, 2004.[Medline]
  11. Coats AJ, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 335: 63–66, 1990.[CrossRef][Web of Science][Medline]
  12. Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F 3rd, DeMets DL, White BG. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 339: 1810–1816, 1998.[Abstract/Free Full Text]
  13. Dall'Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol 47: 757–763, 2006.[Abstract/Free Full Text]
  14. De Sousa E, Veksler V, Bigard X, Mateo P, Ventura-Clapier R. Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102: 1847–1853, 2000.[Abstract/Free Full Text]
  15. Delp MD, Duan C, Mattson JP, Musch TI. Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure. J Appl Physiol 83: 1291–1299, 1997.[Abstract/Free Full Text]
  16. Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y. Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol Lung Cell Mol Physiol 280: L1196–L1202, 2001.[Abstract/Free Full Text]
  17. Filippatos GS, Kanatselos C, Manolatos DD, Vougas B, Sideris A, Kardara D, Anker SD, Kardaras F, Uhal B. Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia. Int J Cardiol 90: 107–113, 2003.[CrossRef][Web of Science][Medline]
  18. Francis J, Weiss RM, Wei SG, Johnson AK, Felder RB. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol 281: R1734–R1745, 2001.[Abstract/Free Full Text]
  19. Gielen S, Adams V, Linke A, Erbs S, Mobius-Winkler S, Schubert A, Schuler G, Hambrecht R. Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle. Eur J Cardiovasc Prev Rehabil 12: 393–400, 2005.[CrossRef][Web of Science][Medline]
  20. Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol 95: 17C–40C, 2005.[CrossRef][Web of Science][Medline]
  21. Gwechenberger M, Hulsmann M, Berger R, Graf S, Springer C, Stanek B, Pacher R. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure. J Heart Lung Transplant 23: 839–844, 2004.[CrossRef][Web of Science][Medline]
  22. Haykowsky MJ, Liang Y, Pechter D, Jones LW, McAlister FA, Clark AM. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 49: 2329–2336, 2007.[Abstract/Free Full Text]
  23. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148: 291–300, 1996.[Abstract]
  24. Hurley BF, Roth SM. Strength training in the elderly: effects on risk factors for age-related diseases. Sports Med 30: 249–268, 2000.[CrossRef][Web of Science][Medline]
  25. Jankord R, Jemiolo B. Influence of physical activity on serum IL-6 and IL-10 levels in healthy older men. Med Sci Sports Exerc 36: 960–964, 2004.[CrossRef][Web of Science][Medline]
  26. Jessen N, Goodyear LJ. Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 99: 330–337, 2005.[Abstract/Free Full Text]
  27. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods 30: 55–67, 1993.[CrossRef][Web of Science][Medline]
  28. Kaur K, Sharma AK, Dhingra S, Singal PK. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 41: 1023–1030, 2006.[CrossRef][Web of Science][Medline]
  29. Kregel K, Allen D, Booth F, Fleshner M, Henriksen E, Musch TI, O'Leary D, Parks C, Poole DC, Ra'anan A, Sheriff D, Sturek M, Toth L. Resource Book for the Design of Animal Exercise Protocols. Bethesda, MD: Am. Physiol. Soc., 2006, p. 35–41.
  30. LeMaitre JP, Harris S, Hannan J, Fox KA, Denvir MA. Maximum oxygen uptake corrected for skeletal muscle mass accurately predicts functional improvements following exercise training in chronic heart failure. Eur J Heart Fail 8: 243–248, 2006.[CrossRef][Web of Science][Medline]
  31. Lindpaintner K, Lu W, Neidermajer N, Schieffer B, Just H, Ganten D, Drexler H. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 25: 133–143, 1993.[CrossRef][Web of Science][Medline]
  32. Lunde PK, Sejersted OM, Thorud HM, Tonnessen T, Henriksen UL, Christensen G, Westerblad H, Bruton J. Effects of congestive heart failure on Ca2+ handling in skeletal muscle during fatigue. Circ Res 98: 1514–1519, 2006.[Abstract/Free Full Text]
  33. Moller P, Wallin H, Knudsen LE. Oxidative stress associated with exercise, psychological stress and life-style factors. Chem Biol Interact 102: 17–36, 1996.[CrossRef][Web of Science][Medline]
  34. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol 19: 683–765, 2001.[CrossRef][Web of Science][Medline]
  35. Musch TI, Wolfram S, Hageman KS, Pickar JG. Skeletal muscle ouabain binding sites are reduced in rats with chronic heart failure. J Appl Physiol 92: 2326–2334, 2002.[Abstract/Free Full Text]
  36. Myers J, Froelicher VF. Hemodynamic determinants of exercise capacity in chronic heart failure. Ann Intern Med 115: 377–386, 1991.[Abstract/Free Full Text]
  37. Niebauer J, Clark AL, Webb-Peploe KM, Coats AJ. Exercise training in chronic heart failure: effects on pro-inflammatory markers. Eur J Heart Fail 7: 189–193, 2005.[CrossRef][Web of Science][Medline]
  38. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515: 287–291, 1999.[Abstract/Free Full Text]
  39. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325: 1468–1475, 1991.[Abstract]
  40. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 98: 1154–1162, 2005.[Abstract/Free Full Text]
  41. Petretta M, Condorelli GL, Spinelli L, Scopacasa F, de Caterina M, Leosco D, Vicario ML, Bonaduce D. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Am Heart J 140: E28, 2000.[CrossRef][Medline]
  42. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503–512, 1979.[Abstract/Free Full Text]
  43. Pfeifer PC, Musch TI, McAllister RM. Skeletal muscle oxidative capacity and exercise tolerance in rats with heart failure. Med Sci Sports Exerc 33: 542–548, 2001.[CrossRef][Web of Science][Medline]
  44. Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328: 189, 2004.[Abstract/Free Full Text]
  45. Pinho RA, Andrades ME, Oliveira MR, Pirola AC, Zago MS, Silveira PC, Dal-Pizzol F, Moreira JC. Imbalance in SOD/CAT activities in rat skeletal muscles submitted to treadmill training exercise. Cell Biol Int 30: 848–853, 2006.[CrossRef][Web of Science][Medline]
  46. Richardson TE, Kindig CA, Musch TI, Poole DC. Effects of chronic heart failure on skeletal muscle capillary hemodynamics at rest and during contractions. J Appl Physiol 95: 1055–1062, 2003.[Abstract/Free Full Text]
  47. Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, Bristow MR, Colucci WS, Sawyer DB. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 11: 473–480, 2005.[CrossRef][Web of Science][Medline]
  48. Strassburg S, Springer J, Anker SD. Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol 37: 1938–1947, 2005.[CrossRef][Web of Science][Medline]
  49. Thackray S, Easthaugh J, Freemantle N, Cleland J. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure–a meta-regression analysis. Eur J Heart Fail 4: 515–529, 2002.[CrossRef][Web of Science][Medline]
  50. Thomas GD, Zhang W, Victor RG. Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress. Circ Res 88: 816–823, 2001.[Abstract/Free Full Text]
  51. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 95: 3C–8C, 2005.[Web of Science][Medline]
  52. Toth MJ, Ades PA, Tischler MD, Tracy RP, LeWinter MM. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol 109: 179–187, 2006.[CrossRef][Web of Science][Medline]
  53. Varin R, Mulder P, Richard V, Tamion F, Devaux C, Henry JP, Lallemand F, Lerebours G, Thuillez C. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 99: 2951–2957, 1999.[Abstract/Free Full Text]
  54. Ventura-Clapier R, De Sousa E, Veksler V. Metabolic myopathy in heart failure. News Physiol Sci 17: 191–196, 2002.[Abstract/Free Full Text]
  55. Zaldivar F, Wang-Rodriguez J, Nemet D, Schwindt C, Galassetti P, Mills PJ, Wilson LD, Cooper DM. Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes. J Appl Physiol 100: 1124–1133, 2006.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/6/1641    most recent
00062.2008v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nunes, R. B.
Right arrow Articles by Dall'Ago, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nunes, R. B.
Right arrow Articles by Dall'Ago, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.